Selected research
Market Analysis & Forecast
Global Fecal Microbiota Transplantation(FMT) Market Analysis and Forecast 2026-2032
Market perspective
The global Fecal Microbiota Transplantation(FMT) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Fecal Microbiota Transplantation(FMT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Fecal Microbiota Transplantation(FMT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Fecal Microbiota Transplantation(FMT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Fecal Microbiota Transplantation(FMT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Fecal Microbiota Transplantation(FMT) include OpenBiome, Ramon Y Cajal, Asia Microbiota Bank, Taymount Clinic, FMT Bank, Birmingham MTC, BiomeBank, GoldBiome and Johns Hopkins, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Fecal Microbiota Transplantation(FMT), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Fecal Microbiota Transplantation(FMT), also provides the revenue of main regions and countries. Of the upcoming market potential for Fecal Microbiota Transplantation(FMT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fecal Microbiota Transplantation(FMT) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fecal Microbiota Transplantation(FMT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Fecal Microbiota Transplantation(FMT) revenue, projected growth trends, production technology, application and end-user industry.
Fecal Microbiota Transplantation(FMT) Segment by Company
OpenBiome
Ramon Y Cajal
Asia Microbiota Bank
Taymount Clinic
FMT Bank
Birmingham MTC
BiomeBank
GoldBiome
Johns Hopkins
Fecal Microbiota Transplantation(FMT) Segment by Type
Fermentation
Fresh
Cryopreservation
Fecal Microbiota Transplantation(FMT) Segment by Application
Intestinal Disease
Extraintestinal Disease
Other
Fecal Microbiota Transplantation(FMT) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fecal Microbiota Transplantation(FMT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fecal Microbiota Transplantation(FMT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fecal Microbiota Transplantation(FMT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Fecal Microbiota Transplantation(FMT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Fecal Microbiota Transplantation(FMT) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fecal Microbiota Transplantation(FMT) revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fermentation
- Fresh
- Cryopreservation
Applications
- Intestinal Disease
- Extraintestinal Disease
- Other
Companies covered
- OpenBiome
- Ramon Y Cajal
- Asia Microbiota Bank
- Taymount Clinic
- FMT Bank
- Birmingham MTC
- BiomeBank
- GoldBiome
- Johns Hopkins
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Fecal Microbiota Transplantation(FMT) Market by Type
- 1.2.1 Global Fecal Microbiota Transplantation(FMT) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Fermentation
- 1.2.3 Fresh
- 1.2.4 Cryopreservation
- 1.3 Fecal Microbiota Transplantation(FMT) Market by Application
- 1.3.1 Global Fecal Microbiota Transplantation(FMT) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Intestinal Disease
- 1.3.3 Extraintestinal Disease
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Fecal Microbiota Transplantation(FMT) Market Dynamics
- 2.1 Fecal Microbiota Transplantation(FMT) Industry Trends
- 2.2 Fecal Microbiota Transplantation(FMT) Industry Drivers
- 2.3 Fecal Microbiota Transplantation(FMT) Industry Opportunities and Challenges
- 2.4 Fecal Microbiota Transplantation(FMT) Industry Restraints
3 Global Growth Perspective
- 3.1 Global Fecal Microbiota Transplantation(FMT) Market Perspective (2021-2032)
- 3.2 Global Fecal Microbiota Transplantation(FMT) Growth Trends by Region
- 3.2.1 Global Fecal Microbiota Transplantation(FMT) Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Fecal Microbiota Transplantation(FMT) Market Size by Region (2021-2026)
- 3.2.3 Global Fecal Microbiota Transplantation(FMT) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Fecal Microbiota Transplantation(FMT) Revenue by Players
- 4.1.1 Global Fecal Microbiota Transplantation(FMT) Revenue by Players (2021-2026)
- 4.1.2 Global Fecal Microbiota Transplantation(FMT) Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Fecal Microbiota Transplantation(FMT) Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Fecal Microbiota Transplantation(FMT) Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Fecal Microbiota Transplantation(FMT) Key Players Headquarters & Area Served
- 4.4 Global Fecal Microbiota Transplantation(FMT) Players, Product Type & Application
- 4.5 Global Fecal Microbiota Transplantation(FMT) Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Fecal Microbiota Transplantation(FMT) Market CR5 and HHI
- 4.6.3 2025 Fecal Microbiota Transplantation(FMT) Tier 1, Tier 2, and Tier 3
5 Fecal Microbiota Transplantation(FMT) Market Size by Type
- 5.1 Global Fecal Microbiota Transplantation(FMT) Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2032)
- 5.3 Global Fecal Microbiota Transplantation(FMT) Revenue Market Share by Type (2021-2032)
6 Fecal Microbiota Transplantation(FMT) Market Size by Application
- 6.1 Global Fecal Microbiota Transplantation(FMT) Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2032)
- 6.3 Global Fecal Microbiota Transplantation(FMT) Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 OpenBiome
- 7.1.1 OpenBiome Company Information
- 7.1.2 OpenBiome Business Overview
- 7.1.3 OpenBiome Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.1.4 OpenBiome Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.1.5 OpenBiome Recent Developments
- 7.2 Ramon Y Cajal
- 7.2.1 Ramon Y Cajal Company Information
- 7.2.2 Ramon Y Cajal Business Overview
- 7.2.3 Ramon Y Cajal Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.2.4 Ramon Y Cajal Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.2.5 Ramon Y Cajal Recent Developments
- 7.3 Asia Microbiota Bank
- 7.3.1 Asia Microbiota Bank Company Information
- 7.3.2 Asia Microbiota Bank Business Overview
- 7.3.3 Asia Microbiota Bank Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.3.4 Asia Microbiota Bank Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.3.5 Asia Microbiota Bank Recent Developments
- 7.4 Taymount Clinic
- 7.4.1 Taymount Clinic Company Information
- 7.4.2 Taymount Clinic Business Overview
- 7.4.3 Taymount Clinic Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.4.4 Taymount Clinic Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.4.5 Taymount Clinic Recent Developments
- 7.5 FMT Bank
- 7.5.1 FMT Bank Company Information
- 7.5.2 FMT Bank Business Overview
- 7.5.3 FMT Bank Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.5.4 FMT Bank Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.5.5 FMT Bank Recent Developments
- 7.6 Birmingham MTC
- 7.6.1 Birmingham MTC Company Information
- 7.6.2 Birmingham MTC Business Overview
- 7.6.3 Birmingham MTC Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.6.4 Birmingham MTC Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.6.5 Birmingham MTC Recent Developments
- 7.7 BiomeBank
- 7.7.1 BiomeBank Company Information
- 7.7.2 BiomeBank Business Overview
- 7.7.3 BiomeBank Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.7.4 BiomeBank Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.7.5 BiomeBank Recent Developments
- 7.8 GoldBiome
- 7.8.1 GoldBiome Company Information
- 7.8.2 GoldBiome Business Overview
- 7.8.3 GoldBiome Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.8.4 GoldBiome Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.8.5 GoldBiome Recent Developments
- 7.9 Johns Hopkins
- 7.9.1 Johns Hopkins Company Information
- 7.9.2 Johns Hopkins Business Overview
- 7.9.3 Johns Hopkins Fecal Microbiota Transplantation(FMT) Revenue and Gross Margin (2021-2026)
- 7.9.4 Johns Hopkins Fecal Microbiota Transplantation(FMT) Product Portfolio
- 7.9.5 Johns Hopkins Recent Developments
8 North America
- 8.1 North America Fecal Microbiota Transplantation(FMT) Revenue (2021-2032)
- 8.2 North America Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2032)
- 8.2.1 North America Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2026)
- 8.2.2 North America Fecal Microbiota Transplantation(FMT) Revenue by Type (2027-2032)
- 8.3 North America Fecal Microbiota Transplantation(FMT) Revenue Share by Type (2021-2032)
- 8.4 North America Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2032)
- 8.4.1 North America Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2026)
- 8.4.2 North America Fecal Microbiota Transplantation(FMT) Revenue by Application (2027-2032)
- 8.5 North America Fecal Microbiota Transplantation(FMT) Revenue Share by Application (2021-2032)
- 8.6 North America Fecal Microbiota Transplantation(FMT) Revenue by Country
- 8.6.1 North America Fecal Microbiota Transplantation(FMT) Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Fecal Microbiota Transplantation(FMT) Revenue by Country (2021-2026)
- 8.6.3 North America Fecal Microbiota Transplantation(FMT) Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Fecal Microbiota Transplantation(FMT) Revenue (2021-2032)
- 9.2 Europe Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2032)
- 9.2.1 Europe Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2026)
- 9.2.2 Europe Fecal Microbiota Transplantation(FMT) Revenue by Type (2027-2032)
- 9.3 Europe Fecal Microbiota Transplantation(FMT) Revenue Share by Type (2021-2032)
- 9.4 Europe Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2032)
- 9.4.1 Europe Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2026)
- 9.4.2 Europe Fecal Microbiota Transplantation(FMT) Revenue by Application (2027-2032)
- 9.5 Europe Fecal Microbiota Transplantation(FMT) Revenue Share by Application (2021-2032)
- 9.6 Europe Fecal Microbiota Transplantation(FMT) Revenue by Country
- 9.6.1 Europe Fecal Microbiota Transplantation(FMT) Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Fecal Microbiota Transplantation(FMT) Revenue by Country (2021-2026)
- 9.6.3 Europe Fecal Microbiota Transplantation(FMT) Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Fecal Microbiota Transplantation(FMT) Revenue (2021-2032)
- 10.2 China Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2032)
- 10.2.1 China Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2026)
- 10.2.2 China Fecal Microbiota Transplantation(FMT) Revenue by Type (2027-2032)
- 10.3 China Fecal Microbiota Transplantation(FMT) Revenue Share by Type (2021-2032)
- 10.4 China Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2032)
- 10.4.1 China Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2026)
- 10.4.2 China Fecal Microbiota Transplantation(FMT) Revenue by Application (2027-2032)
- 10.5 China Fecal Microbiota Transplantation(FMT) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Fecal Microbiota Transplantation(FMT) Revenue (2021-2032)
- 11.2 Asia Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2032)
- 11.2.1 Asia Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2026)
- 11.2.2 Asia Fecal Microbiota Transplantation(FMT) Revenue by Type (2027-2032)
- 11.3 Asia Fecal Microbiota Transplantation(FMT) Revenue Share by Type (2021-2032)
- 11.4 Asia Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2032)
- 11.4.1 Asia Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2026)
- 11.4.2 Asia Fecal Microbiota Transplantation(FMT) Revenue by Application (2027-2032)
- 11.5 Asia Fecal Microbiota Transplantation(FMT) Revenue Share by Application (2021-2032)
- 11.6 Asia Fecal Microbiota Transplantation(FMT) Revenue by Country
- 11.6.1 Asia Fecal Microbiota Transplantation(FMT) Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Fecal Microbiota Transplantation(FMT) Revenue by Country (2021-2026)
- 11.6.3 Asia Fecal Microbiota Transplantation(FMT) Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Fecal Microbiota Transplantation(FMT) Revenue (2021-2032)
- 12.2 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2032)
- 12.2.1 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Type (2021-2026)
- 12.2.2 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Type (2027-2032)
- 12.3 SAMEA Fecal Microbiota Transplantation(FMT) Revenue Share by Type (2021-2032)
- 12.4 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2032)
- 12.4.1 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Application (2021-2026)
- 12.4.2 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Application (2027-2032)
- 12.5 SAMEA Fecal Microbiota Transplantation(FMT) Revenue Share by Application (2021-2032)
- 12.6 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Country
- 12.6.1 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Country (2021-2026)
- 12.6.3 SAMEA Fecal Microbiota Transplantation(FMT) Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst